Join
Live feed
·
INSIDERFilingvia Quantisnow
Processa Pharmaceuticals Inc. logo

Amendment: Chief Development Officer Bigora Sian bought $5,341 worth of shares (1,971 units at $2.71), increasing direct ownership by 36% to 7,481 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PCSA· Processa Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PCSA (Processa Pharmaceuticals Inc.) and more on Quantisnow.